Marika Nestor receives support for research on thyroid cancer


The Drug Discovery and Development Platform at SciLifeLab has granted support to Marika Nestor for the development of radioimmunotherapy against anaplastic thyroid cancer.

Anaplastic thyroid cancer is a very severe cancer type for which there are currently no efficient therapies. In the project that has received support the researchers aim to identify antibodies that can be used in a treatment that attacks cancer cells without harming healthy tissues.

More information:
Marika Nestor’s research
Drug Discovery and Development Platform